FDA Grants Approval for Levocarnitine ANDA217896 by Baxter Healthcare
The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 217896 for Levocarnitine submitted by Baxter Healthcare.
Therapeutic Area
Therapeutic area intelligence for Levocarnitine with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.